Skip directly to content

La señalización medida por citoquinas en la inflamación

Fecha: 
Martes, Febrero 7, 2017
Duración: 
27:09
Conferencista: 
Dra. María Dolores Vazquez Abad
 

Referencias: 

Qi Wu et al. (2005). Airway epithelial cell tolerance to Pseudomonas aeruginosa. Respiratory Research. 6:26

Waldburger JM & Firestein GS. (2009). Garden of therapeutic delights: new targets in rheumatic diseases. Arthritis Res Ther. 2009; 11(1):206.

Vilcek J, Lee TH (1991). Tumor necrosis factor. New insights into the molecular mechanisms of its multiple actions. J Biol Chem. 266(12):7313–7316.

Stelara (Ustekinumab). Highlights for prescribing information. 2009

Actemra (tocilizumab). Highlights for prescribing information. 2011

Taskén K & Aandahl EM (2004). Localized effects of cAMP mediated by distinct routes of protein kinase A. Physiol Rev. 84(1):137-67.

Shuai K & Liu B (2003). Regulation of JAK-STAT signalling in the immune system. Nat Rev Immunol. 3(11):900-11.

Schlessinger J (2000). Cell signaling by receptor tyrosine kinases. Cell. 103(2):211-25.

Scatizzi J & Perlman H (2009). Kelley and Firestein's Textbook of Rheumatology. Eight edition. Cap 20. Saunders Elsevier.

Rommel C &Camps M, Ji H (2007). PI3K delta and PI3K gamma: partners in crime in inflammation in rheumatoid arthritis and beyond? Nat Rev Immunol. 7(3):191-201.

Constantinescu S (2008). Pathway Diagrams_ Jak_Stat Utilization Table en: https://www.cellsignal.com/common/content/content.jsp?id=science-tables-jak-stat

O'Sullivan LA et al (2007). Cytokine receptor signaling through the Jak-Stat-Socs pathway in disease. Mol Immunol. 44(10):2497-506.

O'Shea JJ et al (2002). Cytokine signaling in 2002: new surprises in the Jak/Stat pathway. Cell. 109 Suppl: S121-31

O'Shea JJ et al (2013) .  Janus kinase inhibitors in autoimmune diseases.  Annals of the Rheumatic Diseases. 72:ii111-ii115.

Nakae S et al (2007). Phenotypic differences between Th1 and Th17 cells and negative regulation of Th1 cell differentiation by IL-17. J Leukoc Biol. 81(5):1258-68.

Murphy et al (2008). Janeway's Immunobiology Seventh edition. Garland Science

McInnes I (2009). Kelley and Firestein's Textbook of Rheumatology. Eight edition. Cap 26. Saunders Elsevier.

Mavers M et al. (2009). Intracellular signal pathways: potential for therapies. Curr Rheumatol Rep. 11(5):378-85.

 

https://www.pfizerpro.com.ec/sites/g/files/g10037456/f/201607/XELJANZ-ec...